↓ Skip to main content

Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study

Overview of attention for article published in BMC Pharmacology and Toxicology, February 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study
Published in
BMC Pharmacology and Toxicology, February 2013
DOI 10.1186/2050-6511-14-14
Pubmed ID
Authors

Anthony Cahn, Simon Hodgson, Robert Wilson, Jonathan Robertson, Joanna Watson, Misba Beerahee, Steve C Hughes, Graeme Young, Rebecca Graves, David Hall, Sjoerd van Marle, Roberto Solari

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 21%
Student > Ph. D. Student 7 18%
Student > Bachelor 5 13%
Student > Doctoral Student 3 8%
Professor > Associate Professor 2 5%
Other 5 13%
Unknown 8 21%
Readers by discipline Count As %
Medicine and Dentistry 7 18%
Agricultural and Biological Sciences 5 13%
Immunology and Microbiology 5 13%
Biochemistry, Genetics and Molecular Biology 3 8%
Chemistry 3 8%
Other 7 18%
Unknown 8 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2022.
All research outputs
#7,480,713
of 22,867,327 outputs
Outputs from BMC Pharmacology and Toxicology
#138
of 440 outputs
Outputs of similar age
#64,428
of 193,268 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#4
of 11 outputs
Altmetric has tracked 22,867,327 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 440 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,268 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.